Iodide

Iodide

SCHEMBL9729835

CC(C)CN=C(Cc1ccccc1)N1CC2C(=O)CCC(c3ccccc3)(c3ccccc3)C2C1.I

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 7/20 0.52
MEN1 O00255 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
KMT2A Q03164 1/20 0.52
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
FNTA P49354 1/20 0.30
FNTB P49356 1/20 0.30
CXCR3 P49682 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9730495 0.88 TACR1 (0.55) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730197 0.87 TACR1 (0.53) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729350 0.86 TACR1 (0.53) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729223 0.86 TACR1 (0.56) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730151 0.85 TACR1 (0.52) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729555 0.83 TACR1 (0.50) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730371 0.83 TACR1 (0.54) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729540 0.82 TACR1 (0.51) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730365 0.82 TACR1 (0.51) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730899 0.81 TACR1 (0.55) TACR1MEN1CYP3A4MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5102667-A Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders RHONE-POULENC SANTE (FR) 1992-04-07 US disclosed